Advanced Enzyme Technologies Lt Share Price ₹369

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Advanced Enzyme Technologies Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	139	147	158	161	158	155	146	169	167	186	185	172	203
Expenses +	95	103	107	107	102	103	104	114	122	129	124	123	140
Operating Profit	44	44	51	54	55	51	42	55	46	56	60	49	63
OPM %	32%	30%	32%	33%	35%	33%	29%	33%	27%	30%	33%	29%	31%
Other Income +	7	7	6	14	-6	7	10	8	9	9	10	20	7
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	8	9	9	9	9	9	9	9	10	10	10	10	10
Profit before tax	42	41	48	59	40	49	42	53	43	55	60	58	60
Tax %	24%	29%	27%	28%	25%	28%	21%	27%	38%	26%	25%	26%	24%
Net Profit +	32	29	35	42	30	35	33	39	27	40	45	43	45
EPS in Rs	2.87	2.58	3.08	3.74	2.53	3.05	2.94	3.37	2.37	3.57	3.87	3.80	3.84

Financials of Advanced Enzyme Technologies Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	222	293	329	391	420	444	502	529	541	624	637	746
Expenses +	131	155	177	226	236	241	269	327	382	418	441	517
Operating Profit	91	138	152	165	184	203	232	203	158	206	196	229
OPM %	41%	47%	46%	42%	44%	46%	46%	38%	29%	33%	31%	31%
Other Income +	1	-3	3	1	5	6	9	6	21	21	33	46
Interest	9	8	4	9	5	4	3	3	3	4	5	3
Depreciation	9	9	13	18	21	26	28	35	35	35	37	40
Profit before tax	74	118	137	139	162	179	210	171	140	188	187	233
Tax %	31%	35%	32%	33%	28%	26%	28%	28%	26%	27%	28%	25%
Net Profit +	51	77	93	94	116	133	151	124	104	137	134	174
EPS in Rs	4.60	6.97	8.20	8.07	9.95	11.58	13.09	10.70	9.45	11.92	11.72	15.07
Dividend Payout %	4%	3%	5%	6%	6%	5%	7%	9%	11%	43%	44%	9%

Financials of Advanced Enzyme Technologies Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	22	22	22	22	22	22	22	22	22	22	22	22
Reserves	188	256	442	537	657	817	948	1,066	1,213	1,302	1,398	1,610
Borrowings +	115	101	54	67	35	28	23	35	34	47	39	32
Other Liabilities +	92	71	65	102	91	104	153	137	142	150	151	175
Total Liabilities	417	450	583	727	805	971	1,146	1,260	1,411	1,521	1,611	1,839
Fixed Assets +	287	285	421	491	495	563	601	619	649	650	679	692
CWIP	5	7	8	11	10	10	10	15	22	41	22	51
Investments	0	0	0	0	111	124	121	102	360	403	480	584
Other Assets +	125	158	153	226	188	275	413	524	380	427	430	511
Total Assets	417	450	583	727	805	971	1,146	1,260	1,411	1,521	1,611	1,839

Financials of Advanced Enzyme Technologies Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	54	93	107	116	129	141	163	122	140	141	142	157
Cash from Investing Activity +	-15	-10	-60	-60	-124	-43	-27	2	-286	-65	-89	-74
Cash from Financing Activity +	-36	-63	-65	-2	-43	-39	-26	-48	-26	-59	-73	-70
Net Cash Flow	2	21	-18	54	-38	60	109	75	-171	17	-20	12
Free Cash Flow	42	88	97	105	116	90	143	95	102	94	108	105
CFO/OP	88%	88%	105%	97%	70%	69%	94%	87%	112%	93%	103%	97%

Financials of Advanced Enzyme Technologies Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	52	55	55	51	61	63	61	68	58	66	71
Inventory Days	403	358	352	339	363	361	346	402	343	375	378	335
Days Payable	89	68	57	78	46	43	56	60	67	40	41	76
Cash Conversion Cycle	374	342	351	315	369	379	353	404	344	393	403	331
Working Capital Days	-43	3	76	47	72	90	94	116	109	102	112	402
ROCE %	25%	36%	31%	25%	24%	22%	22%	16%	12%	15%	13%	14%